Gregory B. Brown
CIK: 0001373585
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026AQST
Aquestive Therapeutics, Inc.
Award(A)DirectStock Option (Right to Purchase)
50.5K shares- - Jan 9, 2026LSTA
LISATA THERAPEUTICS, INC.
Award(A)Direct30.5K shares- - Jun 11, 2025AQST
Aquestive Therapeutics, Inc.
Award(A)DirectStock Option (Right to Purchase)
42K shares at avg. $3.41- - Jan 9, 2025LSTA
LISATA THERAPEUTICS, INC.
Award(A)Direct15.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  AQST Aquestive Therapeutics, Inc. | Award(A) Stock Option (Right to Purchase) | 50,500 | - | - | Direct |
| Jan 9, 2026 |  LSTA LISATA THERAPEUTICS, INC. | Award(A) | 30,456 | - | $0 | Direct |
| Jun 11, 2025 | AQST Aquestive Therapeutics, Inc. | Award(A) Stock Option (Right to Purchase) | 42,000 | $3.41 | - | Direct |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | Award(A) | 15,789 | - | $0 | Direct |
1-4 of 4 transactions
About BROWN GREGORY B
BROWN GREGORY B (SEC CIK 0001373585) files insider reports with the SEC as Director of Aquestive Therapeutics, Inc. (AQST) and Director of LISATA THERAPEUTICS, INC. (LSTA).
Signal8 holds 4 ownership filings by BROWN GREGORY B, all Form 4s, filed between Jan 13, 2025 and Jun 12, 2026. Those filings report 4 transactions, from Jan 9, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BROWN GREGORY B's filings is in WARREN, NJ.
Recent filings by BROWN GREGORY B
Other insiders filing for Aquestive Therapeutics, Inc. (AQST)
- Cochran John, Director
- Barber Daniel, President and CEO
- Daly Richard J, Director
- Korczynski Sherry, Chief Commercial Officer
- Boyd Peter E., Chief People Officer
- Jung Cassie, Chief Operating Officer